Cardiovascular Drugs and Sexuality
- 1 October 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 140 (10) , 1341-1345
- https://doi.org/10.1001/archinte.1980.00330210089029
Abstract
• In evaluating the factors of sexual dysfunction of the cardiovascular patient, the impact of drugs should be considered. Cardiovascular drugs may affect the sexuality of the patient through their effects on the CNS and peripheral nervous system, the vascular system, and hormonal changes. Such agents may impair the libidinal, erectile, and orgasmic phases of the human sexual response or may have effects that indirectly affect sexuality. Adrenergic inhibiting drugs, diuretics, vasodilators, monoamine oxidase inhibitors, antiarrhythmics, hypolipidemics, and digitalis may affect the sexual response, with the former group having the most serious effects. These effects may interfere with the patient's compliance with medications, can cause emotional problems, and often have an undesirable impact on marital relations. Knowledge of the sexual side effects of the drugs and proper counseling of the patient are vital. (Arch Intern Med 140:1341-1345, 1980)This publication has 9 references indexed in Scilit:
- Newer concepts in antihypertensive drugsProgress in Cardiovascular Diseases, 1978
- Sexual Life and Sexual Frigidity Among Women Developing Acute Myocardial InfarctionPsychosomatic Medicine, 1976
- Marital Sexual Dysfunction: Erectile DysfunctionAnnals of Internal Medicine, 1976
- Marital Sexual Dysfunction: Introductory ConceptsAnnals of Internal Medicine, 1976
- Evaluation of the effects of drugs on sexual behavior.Published by Wiley ,1976
- Sexual dysfunction resulting from drug side effectsThe Journal of Sex Research, 1974
- Sexual responses to disease processesThe Journal of Sex Research, 1968
- Spironolactone Therapy and GynecomastiaJAMA, 1965
- Gynecomastia During Therapy with SpironolactoneJAMA, 1963